Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors
This study has been completed.
Study NCT00002608 Information provided by National Cancer Institute (NCI)
First Received on November 1, 1999. Last Updated on February 6, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Adrenocortical Carcinoma
Head and Neck Cancer
Liver Cancer
Malignant Mesothelioma
Pheochromocytoma
Sarcoma
Additional conditions recognized in this trial
Carcinoma
Central Nervous System Neoplasms
Head and Neck Neoplasms
Liver Neoplasms
Mesothelioma
Nervous System Neoplasms
More general conditions related to this trial
Adenocarcinoma
Adenoma
Adrenal Cortex Diseases
Adrenal Cortex Neoplasms
Adrenal Gland Diseases
Adrenal Gland Neoplasms
Digestive System Diseases
Digestive System Neoplasms
Endocrine Gland Neoplasms
Endocrine System Diseases
Liver Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Connective and Soft Tissue
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Mesothelial
Neoplasms, Nerve Tissue
Nervous System Diseases
Neuroectodermal Tumors
Neuroendocrine Tumors
Paraganglioma
Interventions listed in this trial
cisplatin
doxorubicin hydrochloride
tamoxifen citrate
conventional surgery
radiation therapy
Additional drug interventions recognized in this trial
Doxorubicin
Tamoxifen
More general drug interventions related to this trial
Antibiotics, Antineoplastic
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Bone Density Conservation Agents
Estrogen Antagonists
Estrogen Receptor Modulators
Hormone Antagonists
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Selective Estrogen Receptor Modulators
Therapeutic Uses
Sponsors listed in this trial
Ottawa Regional Cancer Centre
Back to top of Main Content